Surgery Partners CS (SGRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 821,500 | 826,200 | 776,000 | 864,400 | 770,400 |
| Cost of Goods | 626,200 | 630,600 | 614,100 | 630,800 | 592,900 |
| Gross Profit | 195,300 | 195,600 | 161,900 | 233,600 | 177,500 |
| Operating Expenses | 89,800 | 84,500 | 100,100 | 107,300 | 117,500 |
| Operating Income | 105,700 | 111,700 | 61,900 | 127,100 | 60,900 |
| Interest Expense | 80,100 | 73,400 | 67,800 | 60,100 | 55,200 |
| Other Income | 5,200 | 5,500 | 5,600 | 7,200 | 5,200 |
| Pre-tax Income | 30,800 | 43,800 | -300 | 74,200 | 10,900 |
| Income Tax | 5,500 | -1,100 | N/A | 120,800 | 4,500 |
| Net Income Continuous | 25,300 | 44,900 | -300 | -46,600 | 6,400 |
| Minority Interests | 48,000 | 47,400 | 37,400 | 61,900 | 38,100 |
| Net Income | $-22,700 | $-2,500 | $-37,700 | $-108,500 | $-31,700 |
| EPS Basic Total Ops | -0.18 | -0.02 | -0.30 | -0.86 | -0.25 |
| EPS Basic Continuous Ops | 0.20 | 0.35 | 0.00 | -0.37 | 0.05 |
| EPS Diluted Total Ops | -0.18 | -0.02 | -0.30 | -0.86 | -0.25 |
| EPS Diluted Continuous Ops | 0.20 | 0.35 | 0.00 | -0.37 | 0.05 |
| EPS Diluted Before Non-Recurring Items | N/A | 0.12 | -0.02 | 0.39 | 0.13 |
| EBITDA(a) | $150,400 | $157,500 | $103,800 | $168,200 | $116,300 |